Heparin-released plasma lipase activities, lipoprotein and apoprotein levels in young adult cyclists and sedentary men

Alcohol-induced Hyperlipidemia Is Ameliorated by Orally Administered DWP208, a Sodium Succinate Form of ZYM201

DWP208 is a sodium succinate form of ZYM-201 which is a triterpenoid glycoside isolated from Sanguisorba officinalis, a medicinal plant prescribed for various diseases, such as duodenal ulcers and bleeding in East Asian counties. We demonstrated that this compound is able to normalize the altered lipid metabolism induced by hyperglycemia and a high fat diet. In this study, we determined whether hyperlipidemic conditions induced with chronically treated alcohol can also be restored by DWP208. Similar to our previous results, orally administered DWP208 (1 to 10 mg/kg) also ameliorated the hyperlipidemia that was induced by alcohol. This compound reversed the alcohol-induced hyperlipidemia including (i) up-regulated hyperlipidemic parameters such as low-density lipoprotein (LDL), very low-density lipoprotein (VLDL), atherosclerotic index (AI), triglyceride, and total cholesterol, and (ii) down-regulated hyperlipidemic parameters such as absolute body weight, superoxide dismutase (SOD) activity, and high-density lipoprotein (HDL) in serum and liver. According to our data, the ameliorative activity of DWP208 is due to its indirect anti-oxidative activity as a result of which lipid peroxide and hydroxyl radical levels were reduced and the activity of SOD was enhanced. Therefore, our data strongly suggest that DWP208 can be used as a remedy against alcohol-induced hyperlipidemia.

Effect of age on the response of blood lipids, body composition, and aerobic power to physical conditioning and deconditioning

The influence of age on the response of plasma lipids, body composition, and cardiovascular performance to physical training and detraining was studied in 12 older and 12 young adult male cyclists. The athletes were first examined at the peak of their seasonal preparation and then again 2 months after its suspension. Sedentary males matched for age, weight, and height comprised the respective control groups. During training, body fat mass (BFM) was significantly lower and maximum oxygen consumption (VO2max) higher in both groups of cyclists as compared with controls. No differences in serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein (apo) B, apo A-II, and fibrinogen were found. During the same phase, triglycerides (TG) and the LDL-C to high-density lipoprotein cholesterol (HDL-C) ratio were significantly lower and apo A-I, HDL-C, HDL3-C, and the apo A-I/apo B ratio were significantly higher in the athletes than in their corresponding sedentary controls. After physical deconditioning, BFM increased and VO2max decreased significantly in both groups of athletes. TG, very-low-density lipoprotein cholesterol (VLDL-C), and fibrinogen increased in young athletes while the LDL-C/HDL-C ratio increased, and apo A-I, HDL-C, HDL2-C, and HDL3-C decreased significantly in both young and older athletes. Thus, an aerobic training program induced an antiatherogenic lipoprotein profile and beneficial modifications in body composition and aerobic power in both older and younger subjects; a 2-month interruption in the program changed these parameters unfavorably in both groups. Age does not seem to influence significantly the plasma lipid response to physical deconditioning.

Stress adaptation in athletes: relation of lipoprotein levels to hormonal response

Increased physical stress is produced in acute exercise conditions before and during a physical trial. The effects of the physical stress on lipid and lipoprotein parameters as well as on testosterone and cortisol levels were examined in male elite athletes. In a sample of 22 measured athletes, 11 showed increases and 11 showed decreases in testosterone levels. Subsequently these subjects were treated as two separate groups for statistical purposes in order to characterise the source of individual differences in response to a stressor. Group 1 showed a 16.1% significant increase in testosterone levels, 13.3% in total cholesterol and low density lipoproteins, and a 105% increase in testosterone/cortisol ratio immediately after an acute bout of physical stress of 30 s. Group 2 showed a -25.8% significant decline in testosterone levels and no significant change in either total cholesterol or lipoprotein concentrations, followed by a significant correlation of all lipid and hormonal parameters to psychophysiological factors, such as skin temperature. A measurement of testosterone/cortisol and total cholesterol and high density lipoprotein (HDL-C) levels after a bout of acute physical stress may give a picture of the ability to "respond quickly" to stress, which will be useful in assessing the performance of the elite athlete.

Plasma lipid concentrations in professional cyclists after competitive cycle races

Plasma lipid concentrations were measured in professional cyclists at the beginning of the training season and both before the start and at the end of two cycle races of similar length (800 and 900 km in 6 days). Plasma concentrations of triglyceride, total and low density lipoprotein-cholesterol (LDL-C) and total cholesterol: high density lipoprotein-cholesterol (HDL-C) ratio were significantly lower and HDL-C concentrations significantly higher in cyclists compared to values in matched sedentary controls. At the end of the races, plasma concentrations of triglyceride and LDL-C were further reduced and HDL-C concentrations had increased compared to values at the start. At the end of the races, plasma concentrations of HDL-C were inversely correlated (r = -0.28, n = 45, P less than 0005) with triglyceride plasma concentrations. Body fat content, assessed as the sum of skinfold thicknesses was slightly reduced at the end of the race compared to the starting values. There was no significant correlation between skinfold thickness and plasma concentrations of HDL-C. Total plasma fatty acid concentrations were reduced and nonesterified fatty acids concentrations were increased at the end of the race compared to resting values. Consequently, the plasma concentrations of esterified fatty acids were significantly reduced after the race and there was a redistribution of the nonesterified fatty acids. The relative amounts of single fatty acids in the total fatty acid pool remained, however, remarkably constant. In conclusion, the results presented suggested that physical exercise, performed at the level of professional cyclists in a race, was an independent modifier of plasma lipid concentrations.

Lipid and apoprotein modifications in body builders during and after self-administration of anabolic steroids

To determine the effects of anabolic steroids on serum lipid and apoprotein levels, 14 white male body builders who self-administered steroids for 2 to 3 months (steroid users) were studied; 10 agreed to screening while they were taking the drugs (ON treatment) and also at about 3 months following their suspension (OFF treatment). Controls consisted of 17 body builders who had never taken steroids (nonusers), and a group of 18 healthy sedentary subjects (controls). During the period of steroid administration, there was a slight reduction in total serum cholesterol, with a marked cholesterol decrease in the high-density lipoprotein (HDL) subfractions HDL2 and HDL3, and a significant reduction in the HDL2 cholesterol/HDL3 cholesterol ratio; the percentage of serum cholesterol transported by low-density lipoproteins (LDL) increased significantly. In addition, a marked apoprotein (apo) A-I reduction in the HDL2 and HDL3 subfractions was observed, as well as an apo A-II decrease that was significant only in the HDL3 subfraction, with an A-I/A-II ratio significantly reduced in both subfractions. Serum apo B was only slightly increased, with a very high B/A-I ratio. Apolipoprotein C-II and E levels showed no modifications, while apo C-III reduced significantly. Lipid and apoprotein values returned to almost normal levels in the OFF treatment period. Findings in the group of nonusers were similar to those in sedentary subjects. These results indicate that anabolic steroids profoundly alter the serum lipid-protein profile, and the changes may be caused in part by the significant differences observed in apoprotein levels.